Page last updated: 2024-08-24

3-iodobenzylguanidine and Diffuse Parenchymal Lung Disease

3-iodobenzylguanidine has been researched along with Diffuse Parenchymal Lung Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bertolazzi, C; Cabria, M; Dallorso, S; De Bernardi, B; Garaventa, A; Miano, M; Piccolo, MS; Pizzitola, MR; Villavecchia, GP	1

Trials

1 trial(s) available for 3-iodobenzylguanidine and Diffuse Parenchymal Lung Disease

Article	Year
Megatherapy combining I(131) metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma. Bone marrow transplantation, 2001, Volume: 27, Issue:6 Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Lung Diseases, Interstitial; Male; Neuroblastoma; Radiopharmaceuticals; Transplantation Conditioning; Treatment Outcome	2001

Article

Year

Megatherapy combining I(131) metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma.

Bone marrow transplantation, 2001, Volume: 27, Issue:6

Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Lung Diseases, Interstitial; Male; Neuroblastoma; Radiopharmaceuticals; Transplantation Conditioning; Treatment Outcome

2001